Clinical Trial Update: GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from GlaxoSmithKline evaluating GR270773 for suspected or confirmed gram-negative severe sepsis in adults; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• GR270773

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sepsis | Phase 2 | Status: COMPLETED | Results posted: 2017-05-04